Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis
Carlos R. Cámara-Lemarroy(University of Calgary), V. Wee Yong(University of Calgary), Anthony Traboulsee(University of British Columbia), Jamie Greenfield(University of Calgary), Hans J. Vogel(University of Calgary), Maryam Nakhaei‐Nejad(University of Alberta), Fabrizio Giuliani(University of Alberta), David K.B. Li(University of British Columbia), Reza Dowlatabadi(University of Calgary), Luanne M. Metz(Foothills Medical Centre), Graziela Cerchiaro(University of Calgary), Cláudia Silva(University of North Texas), Chieh-Hsin Lee(Women and Children’s Health Research Institute)
Cited by 5
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k